Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Janssen sponsored industry session at ESMO 2022
Agenda
Learning objective:
After watching this broadcast, participants should be able to:
- Evaluate updates in the molecular diagnosis of EGFR-mutant NSCLC
- Reflect on how recent advances in the management of EGFR-mutant NSCLC may impact clinical practice
Faculty:
- David Planchard (France)
- Rosario García Campelo (Spain)
- Sanjay Popat (UK)
- Paul Hofman (France)
- Anne-Marie Dingemans (Netherlands)
Claim your CPD credits
The content of the following has been certified by the CPD Certification Service as conforming to continuing professional development principles.
You can claim 1.5 credits for this
activity.
Please make a note of the below information
to claim your points.
Name of activity: Precision approaches in EGFR-Mutant NSCLC: Optimising outcomes for patients, 10 September 2022, Paris
Certificate
number: A038287
Date of
activity: October 2022
CPD Provider: Sciterion 013096
More Info
88 Minutes
EM-106732 - Date of preparation: October 2022